Global Patient-derived Xenograft (PDX) Models Competitive Landscape Professional Research Report 2024

Research Summary

Patient-derived xenograft (PDX) models are a type of preclinical research tool used in oncology and cancer research. These models involve transplanting tumor tissues or cells directly from cancer patients into immunodeficient mice or other animal models. PDX models aim to mimic the specific characteristics and behavior of a patient's tumor, allowing researchers to study its growth, response to treatments, and underlying biology in a controlled laboratory setting. PDX models are valuable for drug development and personalized medicine approaches, as they can help identify and test potential therapies and assess how an individual patient's cancer may respond to different treatments. These models bridge the gap between in vitro cell culture studies and human clinical trials, enabling researchers to make more informed decisions about treatment strategies and drug development based on a tumor's real-world behavior.

According to DIResearch's in-depth investigation and research, the global Patient-derived Xenograft (PDX) Models market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.

The major global manufacturers of Patient-derived Xenograft (PDX) Models include Crown Bioscience, Champions Oncology, Wuxi Apptec, The Jackson Laboratory, EPO Berlin-Buch, Oncodesign, Xentech, Envigo, Charles River Laboratories, Pharmatest Services, Urosphere, MEDICILON, Horizon Discovery, Shanghai Model Organisms Center, GemPharmatech, LIDE Biotech etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.

This report studies the market size, price trends and future development prospects of Patient-derived Xenograft (PDX) Models. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Patient-derived Xenograft (PDX) Models market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Patient-derived Xenograft (PDX) Models market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Patient-derived Xenograft (PDX) Models industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Patient-derived Xenograft (PDX) Models Include:

Crown Bioscience

Champions Oncology

Wuxi Apptec

The Jackson Laboratory

EPO Berlin-Buch

Oncodesign

Xentech

Envigo

Charles River Laboratories

Pharmatest Services

Urosphere

MEDICILON

Horizon Discovery

Shanghai Model Organisms Center

GemPharmatech

LIDE Biotech

Patient-derived Xenograft (PDX) Models Product Segment Include:

Mouse Model

Rat Model

Patient-derived Xenograft (PDX) Models Product Application Include:

Preclinical Drug development

Biomarker Analysis

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Patient-derived Xenograft (PDX) Models Industry PESTEL Analysis

Chapter 3: Global Patient-derived Xenograft (PDX) Models Industry Porter's Five Forces Analysis

Chapter 4: Global Patient-derived Xenograft (PDX) Models Major Regional Market Size and Forecast Analysis

Chapter 5: Global Patient-derived Xenograft (PDX) Models Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Patient-derived Xenograft (PDX) Models Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Patient-derived Xenograft (PDX) Models Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Patient-derived Xenograft (PDX) Models Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Patient-derived Xenograft (PDX) Models Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Patient-derived Xenograft (PDX) Models Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Patient-derived Xenograft (PDX) Models Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Patient-derived Xenograft (PDX) Models Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources

Table of Contents

1 Patient-derived Xenograft (PDX) Models Market Overview

1.1 Product Definition and Statistical Scope

1.2 Patient-derived Xenograft (PDX) Models Product by Type

1.2.1 Global Patient-derived Xenograft (PDX) Models Market Size by Type, 2023 VS 2024 VS 2030

1.2.2 Mouse Model

1.2.3 Rat Model

1.3 Patient-derived Xenograft (PDX) Models Product by Application

1.3.1 Global Patient-derived Xenograft (PDX) Models Market Size by Application, 2023 VS 2024 VS 2030

1.3.2 Preclinical Drug development

1.3.3 Biomarker Analysis

1.4 Global Patient-derived Xenograft (PDX) Models Market Revenue Analysis (2019-2030)

1.5 Patient-derived Xenograft (PDX) Models Market Development Status and Trends

1.5.1 Patient-derived Xenograft (PDX) Models Industry Development Status Analysis

1.5.2 Patient-derived Xenograft (PDX) Models Industry Development Trends Analysis

2 Patient-derived Xenograft (PDX) Models Market PESTEL Analysis

2.1 Political Factors Analysis

2.2 Economic Factors Analysis

2.3 Social Factors Analysis

2.4 Technological Factors Analysis

2.5 Environmental Factors Analysis

2.6 Legal Factors Analysis

3 Patient-derived Xenograft (PDX) Models Market Porter's Five Forces Analysis

3.1 Competitive Rivalry

3.2 Threat of New Entrants

3.3 Bargaining Power of Suppliers

3.4 Bargaining Power of Buyers

3.5 Threat of Substitutes

4 Global Patient-derived Xenograft (PDX) Models Market Analysis by Regions

4.1 Patient-derived Xenograft (PDX) Models Overall Market: 2023 VS 2024 VS 2030

4.2 Global Patient-derived Xenograft (PDX) Models Revenue and Forecast Analysis (2019-2030)

4.2.1 Global Patient-derived Xenograft (PDX) Models Revenue and Market Share by Region (2019-2024)

4.2.2 Global Patient-derived Xenograft (PDX) Models Revenue Forecast by Region (2025-2030)

5 Global Patient-derived Xenograft (PDX) Models Market Size by Type and Application

5.1 Global Patient-derived Xenograft (PDX) Models Market Size by Type

5.2 Global Patient-derived Xenograft (PDX) Models Market Size by Application

6 North America

6.1 North America Patient-derived Xenograft (PDX) Models Market Size and Growth Rate Analysis (2019-2030)

6.2 North America Key Manufacturers Analysis

6.3 North America Patient-derived Xenograft (PDX) Models Market Size by Type

6.4 North America Patient-derived Xenograft (PDX) Models Market Size by Application

6.5 North America Patient-derived Xenograft (PDX) Models Market Size by Country

6.5.1 US

6.5.2 Canada

7 Europe

7.1 Europe Patient-derived Xenograft (PDX) Models Market Size and Growth Rate Analysis (2019-2030)

7.2 Europe Key Manufacturers Analysis

7.3 Europe Patient-derived Xenograft (PDX) Models Market Size by Type

7.4 Europe Patient-derived Xenograft (PDX) Models Market Size by Application

7.5 Europe Patient-derived Xenograft (PDX) Models Market Size by Country

7.5.1 Germany

7.5.2 France

7.5.3 United Kingdom

7.5.4 Italy

7.5.5 Spain

7.5.6 Benelux

8 China

8.1 China Patient-derived Xenograft (PDX) Models Market Size and Growth Rate Analysis (2019-2030)

8.2 China Key Manufacturers Analysis

8.3 China Patient-derived Xenograft (PDX) Models Market Size by Type

8.4 China Patient-derived Xenograft (PDX) Models Market Size by Application

9 APAC (excl. China)

9.1 APAC (excl. China) Patient-derived Xenograft (PDX) Models Market Size and Growth Rate Analysis (2019-2030)

9.2 APAC (excl. China) Key Manufacturers Analysis

9.3 APAC (excl. China) Patient-derived Xenograft (PDX) Models Market Size by Type

9.4 APAC (excl. China) Patient-derived Xenograft (PDX) Models Market Size by Application

9.5 APAC (excl. China) Patient-derived Xenograft (PDX) Models Market Size by Country

9.5.1 Japan

9.5.2 South Korea

9.5.3 India

9.5.4 Australia

9.5.5 Indonesia

9.5.6 Vietnam

9.5.7 Malaysia

9.5.8 Thailand

10 Latin America

10.1 Latin America Patient-derived Xenograft (PDX) Models Market Size and Growth Rate Analysis (2019-2030)

10.2 Latin America Key Manufacturers Analysis

10.3 Latin America Patient-derived Xenograft (PDX) Models Market Size by Type

10.4 Latin America Patient-derived Xenograft (PDX) Models Market Size by Application

10.5 Latin America Patient-derived Xenograft (PDX) Models Market Size by Country

10.5.1 Mecixo

10.5.2 Brazil

11 Middle East & Africa

11.1 Middle East & Africa Patient-derived Xenograft (PDX) Models Market Size and Growth Rate Analysis (2019-2030)

11.2 Middle East & Africa Key Manufacturers Analysis

11.3 Middle East & Africa Patient-derived Xenograft (PDX) Models Market Size by Type

11.4 Middle East & Africa Patient-derived Xenograft (PDX) Models Market Size by Application

11.5 Middle East & Africa Patient-derived Xenograft (PDX) Models Market Size by Country

11.5.1 Saudi Arabia

11.5.2 South Africa

12 Market Competition by Manufacturers

12.1 Global Patient-derived Xenograft (PDX) Models Market Revenue by Key Manufacturers (2020-2024)

12.2 Patient-derived Xenograft (PDX) Models Competitive Landscape Analysis and Market Dynamic

12.2.1 Patient-derived Xenograft (PDX) Models Competitive Landscape Analysis

12.2.2 Global Key Manufacturers Headquarter and Key Area Sales

12.2.3 Market Dynamic

13 Key Companies Analysis

13.1 Crown Bioscience

13.1.1 Crown Bioscience Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.1.2 Crown Bioscience Patient-derived Xenograft (PDX) Models Product Portfolio

13.1.3 Crown Bioscience Patient-derived Xenograft (PDX) Models Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.2 Champions Oncology

13.2.1 Champions Oncology Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.2.2 Champions Oncology Patient-derived Xenograft (PDX) Models Product Portfolio

13.2.3 Champions Oncology Patient-derived Xenograft (PDX) Models Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.3 Wuxi Apptec

13.3.1 Wuxi Apptec Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.3.2 Wuxi Apptec Patient-derived Xenograft (PDX) Models Product Portfolio

13.3.3 Wuxi Apptec Patient-derived Xenograft (PDX) Models Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.4 The Jackson Laboratory

13.4.1 The Jackson Laboratory Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.4.2 The Jackson Laboratory Patient-derived Xenograft (PDX) Models Product Portfolio

13.4.3 The Jackson Laboratory Patient-derived Xenograft (PDX) Models Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.5 EPO Berlin-Buch

13.5.1 EPO Berlin-Buch Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.5.2 EPO Berlin-Buch Patient-derived Xenograft (PDX) Models Product Portfolio

13.5.3 EPO Berlin-Buch Patient-derived Xenograft (PDX) Models Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.6 Oncodesign

13.6.1 Oncodesign Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.6.2 Oncodesign Patient-derived Xenograft (PDX) Models Product Portfolio

13.6.3 Oncodesign Patient-derived Xenograft (PDX) Models Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.7 Xentech

13.7.1 Xentech Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.7.2 Xentech Patient-derived Xenograft (PDX) Models Product Portfolio

13.7.3 Xentech Patient-derived Xenograft (PDX) Models Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.8 Envigo

13.8.1 Envigo Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.8.2 Envigo Patient-derived Xenograft (PDX) Models Product Portfolio

13.8.3 Envigo Patient-derived Xenograft (PDX) Models Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.9 Charles River Laboratories

13.9.1 Charles River Laboratories Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.9.2 Charles River Laboratories Patient-derived Xenograft (PDX) Models Product Portfolio

13.9.3 Charles River Laboratories Patient-derived Xenograft (PDX) Models Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.10 Pharmatest Services

13.10.1 Pharmatest Services Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.10.2 Pharmatest Services Patient-derived Xenograft (PDX) Models Product Portfolio

13.10.3 Pharmatest Services Patient-derived Xenograft (PDX) Models Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.11 Urosphere

13.11.1 Urosphere Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.11.2 Urosphere Patient-derived Xenograft (PDX) Models Product Portfolio

13.11.3 Urosphere Patient-derived Xenograft (PDX) Models Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.12 MEDICILON

13.12.1 MEDICILON Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.12.2 MEDICILON Patient-derived Xenograft (PDX) Models Product Portfolio

13.12.3 MEDICILON Patient-derived Xenograft (PDX) Models Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.13 Horizon Discovery

13.13.1 Horizon Discovery Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.13.2 Horizon Discovery Patient-derived Xenograft (PDX) Models Product Portfolio

13.13.3 Horizon Discovery Patient-derived Xenograft (PDX) Models Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.14 Shanghai Model Organisms Center

13.14.1 Shanghai Model Organisms Center Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.14.2 Shanghai Model Organisms Center Patient-derived Xenograft (PDX) Models Product Portfolio

13.14.3 Shanghai Model Organisms Center Patient-derived Xenograft (PDX) Models Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.15 GemPharmatech

13.15.1 GemPharmatech Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.15.2 GemPharmatech Patient-derived Xenograft (PDX) Models Product Portfolio

13.15.3 GemPharmatech Patient-derived Xenograft (PDX) Models Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.16 LIDE Biotech

13.16.1 LIDE Biotech Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.16.2 LIDE Biotech Patient-derived Xenograft (PDX) Models Product Portfolio

13.16.3 LIDE Biotech Patient-derived Xenograft (PDX) Models Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

14 Industry Chain Analysis

14.1 Patient-derived Xenograft (PDX) Models Industry Chain Analysis

14.2 Patient-derived Xenograft (PDX) Models Industry Raw Material and Suppliers Analysis

14.2.1 Upstream Key Raw Material Supply Analysis

14.2.2 Raw Material Suppliers and Contact Information

14.3 Patient-derived Xenograft (PDX) Models Typical Downstream Customers

14.4 Patient-derived Xenograft (PDX) Models Sales Channel Analysis

15 Research Findings and Conclusion

16 Methodology and Data Source

16.1 Methodology/Research Approach

16.2 Research Scope

16.3 Benchmarks and Assumptions

16.4 Date Source

16.4.1 Primary Sources

16.4.2 Secondary Sources

16.5 Data Cross Validation

16.6 Disclaimer

Name*

Email ID*

Company*

Phone (With Country Code)*

What is/are your question(s)?:

Publisher: DIResearch

Related Reports

Intrauterine Devices Market By Product Type (Hormonal Intrauterine Device and Copper Intrauterine Device), By Material (Plastic, Copper and Hormonal (Levonorgestrel)), By Age Group (15-24 years, 25-34 years, 35-44 years and Above 44 years), By End-user (Hospital, Gynecology Clinics, Community Health Care Centers and Others), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035

Arterial Thrombectomy Devices Market By Device Type (Aspiration Thrombectomy Devices, Mechanical Thrombectomy Devices, Rheolytic Thrombectomy Devices, Ultrasound-Assisted Thrombectomy Devices, Laser-Based Thrombectomy Devices, Others), By Application (Peripheral Arterial Disease (PAD), Coronary Artery Disease (CAD), Ischemic Stroke, Renal Artery Thrombosis, Acute limb Ischemia, Others), By End-user (Hospitals, Specialty Clinics, Ambulatory Surgical Centers (ASCs), Academic and Research Institutions), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035

Global Operating Room Infection Control Consumable Competitive Landscape Professional Research Report 2024

Global Oral Fluid Drug Test System Competitive Landscape Professional Research Report 2024

Global Orthopaedics Competitive Landscape Professional Research Report 2024

Why Market Study Report?

Best Price for Reports
Large Report Database
Easily Customize Reports
24/7 Email & Phone Support